Nuformix (LON:NFX) Issues Earnings Results

Nuformix (LON:NFX) announced its earnings results on Wednesday. The company reported GBX (0.46) (($0.01)) earnings per share for the quarter, Digital Look Earnings reports.

Nuformix Trading Down 24.1 %

Shares of NFX traded down GBX 0.04 ($0.00) on Wednesday, hitting GBX 0.11 ($0.00). 489,925,500 shares of the stock traded hands, compared to its average volume of 79,592,914. Nuformix has a 1 year low of GBX 0.04 ($0.00) and a 1 year high of GBX 0.34 ($0.00). The stock’s 50 day moving average is GBX 0.06 and its two-hundred day moving average is GBX 0.10. The firm has a market capitalization of £901,241.00, a P/E ratio of -1.63 and a beta of 1.22. The company has a quick ratio of 3.35, a current ratio of 1.12 and a debt-to-equity ratio of 1.17.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.